resiquimod has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, M; Huang, P; Li, C; Lin, W; Liu, C; Nasu, Y; Sun, R; Watanabe, M; Xu, A; Xu, N; Xue, R | 1 |
1 other study(ies) available for resiquimod and Prostatic Neoplasms
| Article | Year |
|---|---|
Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Line, Tumor; Cell Survival; Dendritic Cells; Endocytosis; Humans; Imidazoles; Indocyanine Green; Lasers; Male; Mice, Inbred C57BL; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms | 2021 |